Table 2 Clinical and pathological characteristics of patients with FGFR3 gene aberrations detected in surgical specimens
From: Fibroblast growth factor receptor 3 (FGFR3) aberrations in muscle-invasive urothelial carcinoma
Patient | Age | Gender | Primary site | Pathologic stage | Grade | LVI | FGFR3 |
|---|---|---|---|---|---|---|---|
TCC_03 | 64 | M | Bladder | pT3N0 | 3 | No | FGFR3-TACC3 fusion |
TCC_07 | 58 | M | Bladder | pT2N0 | 2 | No | Y373C |
TCC_13 | 47 | M | Bladder | pT2N2 | 2 | Yes | R248C |
TCC_14 | 61 | M | Bladder | pT3N0 | 2 | No | G370C |
TCC_19 | 66 | M | Bladder | pT3N0 | 2 | No | 746_747insG (NM_000142) |
TCC_41 | 55 | M | Renal pelvis | pT3Nx | 2 | No | FGFR3-TACC3 fusion |
TCC_44 | 71 | M | Renal pelvis | pT3Nx | 3 | Yes | N532D |
TCC_48 | 50 | M | Bladder | pT4N3 | 3 | No | S249C |
TCC_49 | 63 | M | Bladder | pT1N2 | 2 | Yes | A797P |
TCC_50 | 59 | F | Ureter | pT3N1 | 2 | No | N532D |
TCC_55 | 73 | M | Bladder | pT2N0 | 2 | No | S675S |
TCC_56 | 54 | F | Renal pelvis | pT3Nx | 2 | No | Y373C |
TCC_61 | 78 | M | Ureter | pT3Nx | 3 | No | Y373C |
TCC_63 | 55 | M | Ureter | pT3N2 | 3 | Yes | R248C |
TCC_70 | 66 | M | Bladder | pT4N0 | 2 | No | N532D |
TCC_71 | 80 | M | Bladder | pT2N0 | 2 | No | FGFR3-TACC3 fusion |